Peptide for regulation of tissue plasminogen activator
CA 2453309 A1 · Owner: Higazi, Abd Al-Roof · Inventors: Higazi, Abd Al-Roof
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the polypeptide the use of the polypeptide , in the prevention and/or treatment of side effects induced by plasminogen activators, specifically tPA or uPA. The invention further relates to combination compositions and/or therapy regimens comprising the polypeptide , and one or more currently used plasminogen activators and methods to achieve , improved fibrinolytic efficacy as well as reducing their side effects.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.